Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
clinical trials
detroit blog main
detroit top stories
eisai
3
×
indiana blog main
indiana top stories
life sciences
national
national blog main
national top stories
new york blog main
new york top stories
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
alzheimer's disease
biogen
biotech
bristol-myers squibb
cancer
fda
galapagos nv
nonalcoholic steatohepatitis
pfizer
sarepta therapeutics
89bio
abbvie
What
drug
3
×
alzheimer’s
bio
roundup
week
aducanumab
amyloid
angst
annual
assessed
attention
bagged
billions
biogen
biogen’s
biotech
brammer
cancer
communities
conference
effects
eisai
esmo
europe
failure
fda
felt
flags
germany
higher
hosted
incidence
investment
lorcaserin
loss
lost
market
marketing
medicine
munich
Language
unset
Current search:
eisai
×
drug
×
@xconomy.com
4 years ago
Eisai Pulls Weight Loss Drug From Market After FDA Flags Cancer Risks
@xconomy.com
5 years ago
Bio Roundup: Amyloid Angst, NASH News, Brammer Bagged & More
@xconomy.com
5 years ago
Bio Roundup: Alzheimer’s Puzzle, ESMO Assessed, Drug Prices & More